Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-04

Clinical Trial Update: Effect of Photodymamic Therapy With Urucum and LED in the Reduction of Halitosis [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial evaluating photodynamic therapy using Urucum and LED to reduce halitosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Photodynamic therapy with Urucum and LED

Snippet

Sponsor: University of Nove de Julho | Conditions: Halitosis | Phase 2 | Status: UNKNOWN